| 000 | 01806 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250511202138.0 | ||
| 264 | 0 | _c19920608 | |
| 008 | 199206s 0 0 eng d | ||
| 022 | _a0160-2446 | ||
| 024 | 7 |
_a10.1097/00005344-199112000-00001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKitzen, J M | |
| 245 | 0 | 0 |
_aAntithrombotic activity of the phosphodiesterase III inhibitor pelrinone in a canine model of coronary artery thrombosis: enhancement of efficacy with concurrent alpha 2-adrenergic antagonism. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular pharmacology _cDec 1991 |
||
| 300 |
_a777-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenosine Diphosphate _xpharmacology |
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
| 650 | 0 | 4 |
_aCoronary Thrombosis _xdrug therapy |
| 650 | 0 | 4 |
_aDioxanes _xadministration & dosage |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aIdazoxan |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
| 700 | 1 | _aMcCallum, J D | |
| 700 | 1 | _aHarvey, C | |
| 700 | 1 | _aMorin, M E | |
| 773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 18 _gno. 6 _gp. 777-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00005344-199112000-00001 _zAvailable from publisher's website |
| 999 |
_c1732284 _d1732284 |
||